Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (5): 810-812    DOI: 10.31083/j.ejgo.2020.05.5328
Case Report Previous articles | Next articles
Ectopic pregnancy concomitant with borderline ovarian tumor
Ana Carolinne da Silva1, Isac Souza Silva Rodrigues1, Antônio Carlos Oliveira de Meneses2, Eddie Fernando Candido Murta1, Rosekeila Simões Nomelini1, *()
1Research Institute of Oncology (IPON)/Department of Gynecology and Obstetrics, Federal University of Triângulo Mineiro, Avenida Getúlio Guaritá, 214. Bairro Abadia. 38025-440. Uberaba – MG Brazil
2Service of Surgical Pathology, Federal University of Triângulo Mineiro, Avenida Getúlio Guaritá, 214. Bairro Abadia. 38025-440. Uberaba – MG Brazil
Download:  PDF(392KB)  ( 109 ) Full text   ( 11 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
The most common clinical presentation of ectopic pregnancy is vaginal bleeding in the first trimester and abdominal pain. The existence of a borderline tumor concomitant to ectopic pregnancy has not been described in the literature. The study reported a patient with ectopic pregnancy undergoing surgical treatment, and during the procedure was found an ovarian cyst. Histopathology confirmed the diagnosis of borderline serous cystadenoma. The article demonstrates the need for anatomic-pathological investigation of ovarian cysts, and especially the surgical care in the approach of ectopic pregnancy concomitant with these cysts, since it can occur in women who still desire children, aiming at the maintenance of fertility.
Key words:  Ectopic pregnancy      Borderline serous cystadenoma      Surgical procedure      Ovarian neoplasms     
Submitted:  01 August 2019      Accepted:  28 October 2019      Published:  15 October 2020     
*Corresponding Author(s):  rosekeila@terra.com.br; rosekeila.nomelini@pq.cnpq.br (Rosekeila Simões Nomelini)   

Cite this article: 

Ana Carolinne da Silva, Isac Souza Silva Rodrigues, Antônio Carlos Oliveira de Meneses, Eddie Fernando Candido Murta, Rosekeila Simões Nomelini. Ectopic pregnancy concomitant with borderline ovarian tumor. European Journal of Gynaecological Oncology, 2020, 41(5): 810-812.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.05.5328     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I5/810

[1] Xiaofeng Xu, Xuan Zhou, Yijin Wang, Tao Liu, Jian Fu, Qian Yang, Jun Wu, Huaijun Zhou. Survival-associated transcriptome analysis in ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 455-461.
[2] N. Tug, M. Yassa, M. Akif Sargın, B. Dogan Taymur, K. Sandal, Ertunc Mega. Preoperative discriminating performance of the IOTA-ADNEX model and comparison with Risk of Malignancy Index: an external validation in a non-gynecologic oncology tertiary center[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 200-207.
[3] Dong-Hee Kim, Seung-Do Choi, Hae-Hyeog Lee, Tae-Hee Kim, Yeon-Suk Kim, Yesol Kim. The role of vitamin D up-regulated protein 1 in epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 585-592.
[4] K. Chikazawa, S. Netsu, K. Akashi, Y. Suzuki, D. Hotta, R. Konno. Feasibility and tolerability of bevacizumab: a retrospective study in Japanese ovarian cancer patients[J]. European Journal of Gynaecological Oncology, 2018, 39(5): 790-794.
[5] R.S. Nomelini, L.J. de Carvalho Oliveira, B.M. Tavares-Murta, E.F.C. Murta. Parameters of blood count and tumor markers: a retrospective analysis and relation to prognostic factors in ovarian cancer[J]. European Journal of Gynaecological Oncology, 2017, 38(3): 364-367.
[6] A. Zwierzchowska, G. Panek, M. Gajewska, E. Barcz. Endometriotic lesions mimicking advanced ovarian cancer - A case report and a review of the literature[J]. European Journal of Gynaecological Oncology, 2017, 38(2): 303-307.
[7] T. Li, J. Tan, P. Cohen. A novel surgical technique for the large ovarian cystic mass – combined mini-laparotomy and laparoscopy[J]. European Journal of Gynaecological Oncology, 2016, 37(6): 766-770.
[8] A. Gómez-Portilla, R. Bustamante, E. López de Heredia, L.I. Lete, M. Cuadra, S. DomÍnguez. Growing teratoma syndrome: an unusual evolution of treated ovarian immature teratoma - a case report[J]. European Journal of Gynaecological Oncology, 2016, 37(5): 729-731.
[9] T.Y. Liu, Y.X. Zhu, P.Q. Ke, M. He, Y.C. Liang, S.Z. Yao. An unusual ovarian neoplasm diagnosed in a patient with rupture of unicornuate uterus during pregnancy: a case report[J]. European Journal of Gynaecological Oncology, 2016, 37(5): 732-735.
[10] P. Jarmużek, G. Panek, M. Gajewska, M. Wielgoś. Ovarian cancer diagnosed accidentally during treatment for ruptured ectopic pregnancy: is fertility-sparing surgery a viable alternative? Case report and review of the literature[J]. European Journal of Gynaecological Oncology, 2016, 37(2): 282-285.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Akanksha Agrawal, Deepanshu Jain, Pradhum Ram, Jorge Luis Penalver Leon, Janani Rangaswami. Anticoagulation for intra-cardiac thrombi in peripartum cardiomyopathy: A review of the literature[J]. Reviews in Cardiovascular Medicine, 2019, 20(2): 53 -58 .
[3] B. Soltész, J. Lukács, A. Penyige, R. Póka, B. Nagy. Determination of miR-193b rs30236 single nucleotide polymorphism in ovarian cancer patients[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 547 -550 .
[4] Y. Li, C. Li, N. Li, L. Jiang, W. Yang, Y. Wang, B. Wu, C. Shi, Z. Zhu. RNAi silenced NUP88 gene suppresses growth and invasiveness of human breast cancer cell line MCF-7[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 634 -639 .
[5] M. Pakiž, L. Lukman, N. Kozar. Patients' and physicians' expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 781 -786 .
[6] T. Tomimatsu, S. Mabuchi, T. Tsuboyama, Y. Hori, S. Sekine, T. Kimura. Malignant transformation of uterine leiomyoma: suggested by clinical, imaging, histological, and genetic findings[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 879 -882 .
[7] Z. Protrka, P. Arsenijevic, N. Jovic, S. Zivanovic, J. Djuric, A. Dimitrijevic. A case of uterine torsion in term pregnancy associated with placental abruption and intrauterine fetal demise[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 287 -289 .
[8] T. Ueno, H. Yabushita, K. Iwasaki, A. Wakatsuki. Role of adiponectin and leptin in non-diabetic, non-obese patients with endometrial cancer[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 199 -204 .
[9] P. Pimsi, W. Santimaleeworagun, S. Therasakvichya, N. Saengsukkasemsak, A. Laocharoenkeat. The incidence and risk factors of severe neutropenia and febrile neutropenia due to chemotherapy among gynecologic cancer patients in Thailand[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 242 -246 .
[10] F. Lai-Tiong. Dermatomyositis revealing a 18-year breast cancer recurrence[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 292 -293 .